Posted inBiotechnology
Inflammation biotech Evommune heads to NYSE with $150M IPO
Evommune is heading to the New York Stock Exchange this morning via a $150 million IPO the inflammation biotech will…
Posted inBiotechnology
Exploring Orthorexia’s Impact on High School Self-Esteem
In recent years, a growing concern has emerged regarding the mental health of adolescents, specifically concerning their relationship with food…
Posted inBiotechnology
Diverse Aryne Derivatives Synthesized from Acids
In the relentless pursuit of novel therapeutic agents and agrochemicals, the construction of densely substituted aromatic rings remains a cornerstone…
Posted inBiotechnology
Enhancing Infant MRI: Deep Learning vs. Anesthesia
In a groundbreaking study set to be published in the esteemed journal Pediatric Radiology, a team of researchers led by…
Posted inBiotechnology
AstraZeneca drops MASH drug over disappointing phase 2 data
AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a…
Posted inBiotechnology
Breakthrough in Quantum Physics: First Successful Demonstration of Entanglement Swapping via Sum-Frequency Generation of Single Photons
In a groundbreaking development in the field of quantum communication, researchers at the National Institute of Information and Communications Technology…
Posted inBiotechnology
New Combination Therapy Shows Promise in Reducing Lifelong Ibrutinib Use for Chronic Lymphocytic Leukemia
In a groundbreaking advancement for the treatment of chronic lymphocytic leukemia (CLL), researchers have unveiled promising results from a phase…
Posted inBiotechnology
Dynavax pays Vaxart $30M for oral COVID-19 vaccine program
Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine, positioning the biotech to see phase…
Posted inMedical Technology
IceCure’s cryoablation treatment may extend survival in some lung cancer patients, study finds
Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting…
Posted inMedical Technology
Illumina shares rise as China set to lift sequencer export ban
China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. Since March, Illumina…